BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 11086089)

  • 21. Protection against respiratory syncytial virus infection by DNA immunization.
    Li X; Sambhara S; Li CX; Ewasyshyn M; Parrington M; Caterini J; James O; Cates G; Du RP; Klein M
    J Exp Med; 1998 Aug; 188(4):681-8. PubMed ID: 9705950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy--a review.
    Becker Y
    Virus Genes; 2006 Oct; 33(2):235-52. PubMed ID: 16972040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucosal delivery of a respiratory syncytial virus CTL peptide with enterotoxin-based adjuvants elicits protective, immunopathogenic, and immunoregulatory antiviral CD8+ T cell responses.
    Simmons CP; Hussell T; Sparer T; Walzl G; Openshaw P; Dougan G
    J Immunol; 2001 Jan; 166(2):1106-13. PubMed ID: 11145691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models.
    Lambert SL; Aslam S; Stillman E; MacPhail M; Nelson C; Ro B; Sweetwood R; Lei YM; Woo JC; Tang RS
    PLoS One; 2015; 10(3):e0119509. PubMed ID: 25793508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-lasting balanced immunity and protective efficacy against respiratory syncytial virus in mice induced by a recombinant protein G1F/M2.
    Zeng R; Qi X; Gong W; Mei X; Wei L; Ma C; Yin X
    Vaccine; 2007 Oct; 25(42):7422-8. PubMed ID: 17850930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shifting immunodominance pattern of two cytotoxic T-lymphocyte epitopes in the F glycoprotein of the Long strain of respiratory syncytial virus.
    Johnstone C; de León P; Medina F; Melero JA; García-Barreno B; Val MD
    J Gen Virol; 2004 Nov; 85(Pt 11):3229-3238. PubMed ID: 15483236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell responses.
    Matyushenko V; Kotomina T; Kudryavtsev I; Mezhenskaya D; Prokopenko P; Matushkina A; Sivak K; Muzhikyan A; Rudenko L; Isakova-Sivak I
    Antiviral Res; 2020 Oct; 182():104864. PubMed ID: 32585323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice.
    Tripp RA; Moore D; Jones L; Sullender W; Winter J; Anderson LJ
    J Virol; 1999 Sep; 73(9):7099-107. PubMed ID: 10438795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunopathology in RSV infection is mediated by a discrete oligoclonal subset of antigen-specific CD4(+) T cells.
    Varga SM; Wang X; Welsh RM; Braciale TJ
    Immunity; 2001 Oct; 15(4):637-46. PubMed ID: 11672545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection.
    Chang J; Srikiatkhachorn A; Braciale TJ
    J Immunol; 2001 Oct; 167(8):4254-60. PubMed ID: 11591747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Priming with a secreted form of the fusion protein of respiratory syncytial virus (RSV) promotes interleukin-4 (IL-4) and IL-5 production but not pulmonary eosinophilia following RSV challenge.
    Bembridge GP; Lopez JA; Bustos R; Melero JA; Cook R; Mason H; Taylor G
    J Virol; 1999 Dec; 73(12):10086-94. PubMed ID: 10559323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonotype-specific avidity influences the dynamics and hierarchy of virus-specific regulatory and effector CD4(+) T-cell responses.
    Liu J; Cao S; Peppers G; Kim SH; Graham BS
    Eur J Immunol; 2014 Apr; 44(4):1058-68. PubMed ID: 24510524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-DP4 presents an immunodominant peptide from the RSV G protein to CD4 T cells.
    de Graaff PM; Heidema J; Poelen MC; van Dijk ME; Lukens MV; van Gestel SP; Reinders J; Rozemuller E; Tilanus M; Hoogerhout P; van Els CA; van der Most RG; Kimpen JL; van Bleek GM
    Virology; 2004 Sep; 326(2):220-30. PubMed ID: 15302208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice.
    Boyoglu-Barnum S; Chirkova T; Todd SO; Barnum TR; Gaston KA; Jorquera P; Haynes LM; Tripp RA; Moore ML; Anderson LJ
    J Virol; 2014 Sep; 88(18):10569-83. PubMed ID: 24990999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a CD4 T cell epitope in the pneumonia virus of mice glycoprotein and characterization of its role in protective immunity.
    Claassen EA; van Bleek GM; Rychnavska ZS; de Groot RJ; Hensen EJ; Tijhaar EJ; van Eden W; van der Most RG
    Virology; 2007 Nov; 368(1):17-25. PubMed ID: 17632195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination with recombinant alphavirus or immune-stimulating complex antigen against respiratory syncytial virus.
    Chen M; Hu KF; Rozell B; Orvell C; Morein B; Liljeström P
    J Immunol; 2002 Sep; 169(6):3208-16. PubMed ID: 12218139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of recombinant respiratory syncytial viruses with the region responsible for type 2 T-cell responses and pulmonary eosinophilia deleted from the attachment (G) protein.
    Elliott MB; Pryharski KS; Yu Q; Boutilier LA; Campeol N; Melville K; Laughlin TS; Gupta CK; Lerch RA; Randolph VB; LaPierre NA; Dack KM; Hancock GE
    J Virol; 2004 Aug; 78(16):8446-54. PubMed ID: 15280453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-4 diminishes CD8(+) respiratory syncytial virus-specific cytotoxic T-lymphocyte activity in vivo.
    Aung S; Tang YW; Graham BS
    J Virol; 1999 Nov; 73(11):8944-9. PubMed ID: 10515999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-9 regulates pathology during primary and memory responses to respiratory syncytial virus infection.
    Dodd JS; Lum E; Goulding J; Muir R; Van Snick J; Openshaw PJ
    J Immunol; 2009 Dec; 183(11):7006-13. PubMed ID: 19915054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.